NHS spent £100 million on post last year

The NHS spent at least £102 million on posting letters last year despite pledging to go digital because of unreliable deliveries.
The amount spent on sending mail, which can regularly arrive late and cause missed appointments, was up by 12.5 per cent on the year before, according to new research by the Taxpayers' Alliance.
The research results have been released as the health service is about to get £30 billion more over three years in Rachel Reeves's spending review this week, to the detriment of other public services.
They also revealed the NHS could make major savings in electricity and laundry costs, as well as reducing the eight million missed appointments that occur each year.
The Telegraph previously revealed that the Royal Mail was introducing a new NHS barcode to cut late deliveries and the risk of missed appointments.
But health officials have also pledged to do more to communicate with patients online and through the NHS app.
Last week, the Department of Health said the app would become the default method of communication for patients seeking appointment reminders, screening invitations and test results as part of a major investment that would mean 50 million fewer letters are posted each year.
The research from the Taxpayers' Alliance found that at least £102 million was spent in 2023-24 across 120 NHS hospital trusts, an average of £850,000 each.
The researchers said this was a 'growing expense' with the costs rising by 12.5 per cent on the £90.3 million spent in 2022-23.
Previous research found that as many as one in four of the eight million appointments that patients miss each year were because letters to patients arrived after the date of the planned appointment.
Simon Cook, a research fellow of the Taxpayers' Alliance, said the public 'expect the NHS to double down on cutting any inefficient and wasteful expenditure'.
'With the health service facing financial pressures, there are huge savings to be made through simple, common sense changes,' he said.
'Ministers must recognise that sometimes the biggest savings don't always require major reforms, just the will to act.'
The research paper also found that the NHS could save more than £150 million on electricity costs if it utilised its buying power.
It said the average cost of electricity across NHS trusts in England was 30.5p per kWh in 2023-24, which was 'typically the rate that medium-sized businesses pay'.
£154m potential laundry savings
The NHS is the biggest single employer in Europe and 'if every NHS trust paid the average extra-large non-domestic consumer price of 22.6p, the saving would amount to £154 million in 2023-24,' the researchers said.
The researchers also found significant discrepancies across the country in the amount being spent on laundry.
While the NHS spent £270 million to launder 555 million items at an average cost of 48.7p per item, some areas achieved lower costs of 25p per item, while others spent £1.20.
A Department of Health and Social Care spokesman said: 'This government inherited a broken NHS with wasteful spending, in desperate need of reform.
'Yesterday, we announced major investment in the NHS app to turbocharge our digital revolution – saving hundreds of millions in taxpayers' money spent on stamps and envelopes, and enabling push notifications and reminders to help cut missed appointments. We are also cutting NHS energy bills through solar power and renewable energy – delivering further savings for the taxpayer.
'Through our Plan for Change, we are reforming the NHS to ensure that every penny is spent on what matters most.'
An NHS England spokesman said: 'Millions of patients are already receiving appointment reminders, screening invitations, and test results direct to their smartphones from the NHS, saving millions of pounds, avoiding the need for letters and freeing-up resources for patient care.
'People without access to smartphones and elderly patients will still receive messages through traditional routes such as letters to ensure they don't miss important information.
'The NHS is continually exploring ways to achieve the best possible value for taxpayers, including making targeted investment in technologies that can enable us to optimise our resources and boost productivity.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Sky News

32 minutes ago

• Sky News

GPs can prescribe weight loss jabs on the NHS from today - but strict eligibility criteria in place

Why you can trust Sky News GPs will be able to prescribe weight loss jabs on the NHS from today. - with strict criteria for the first year of the rollout. Initially, only those with a body mass index of over 40 who have at least four other health problems linked to obesity will be eligible. 0:21 Some doctors have raised concerns about the additional workload this new programme will bring, while pharmacists fear it could lead to supply shortages. While an estimated 1.5 million people are now taking weight loss drugs across the UK, they could previously only be accessed through specialist services or private prescriptions. Dr Claire Fuller from NHS England said: "We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health - and greater access to weight loss drugs will make a significant difference to the lives of those people." She added: "While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional." 1:22 The chairwoman of the Royal College of GPs welcomed NHS England's decision to pursue a phased rollout, and said current workloads must be factored in to ensure the jabs can be prescribed safely. Professor Kamila Hawthorne went on to say: "While weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. "We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later." 9:19 Her remarks were echoed by the National Pharmacy Association's chairman Olivier Picard, who says "prescribing these medications alone misses the point". He argued that they need to be part of a comprehensive strategy that includes lifestyle coaching, exercise and nutritional guidance - but many GPs currently "lack the bandwidth" to provide this support. "As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends - simply because the foundational lifestyle changes weren't addressed," Mr Picard added. Estimates suggest about 29% of the adult population is obese.

The Independent

34 minutes ago

• The Independent

Ukraine-Russia war live: Moscow's wartime toll hits grim milestone while massive drone attack injures five in Kyiv

Nearly one million Russian soldiers have been killed or injured in the Ukraine war, according to the British defence ministry and an American think tank. The defence ministry says over a million Russian soldiers have died or suffered injuries during the war, which started on 24 February 2022. The estimates align with a study by the American think tank Centre for Strategic and International Studies. The think tank estimates Russian deaths at around 250,000 and total casualties, including the wounded, at nearly 950,000, the Guardian reported. The Ukrainian death toll it puts at between 60,000 and 100,000 and total casualties up to 400,000. In continuing hostilities, an overnight Russian drone attack on Kyiv killed five civilians, sparked fires in residential areas and damaged an entrance to a metro station, Ukrainian authorities said on Monday.

Leader Live

3 hours ago

• Leader Live

Mass rollout of weight loss jabs begins on NHS

Around 220,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years. The drug is an antidiabetic drug which lowers blood sugar levels and and slows down how quickly food is digested. From Monday, GPs in England will be allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health problems. Patients previously needed to access the drugs through a special weight loss service. But leading family doctors said some GPs have expressed concern about the additional workload linked to the rollout. And pharmacy experts also said there could be pressure on supplies of the drug. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. Dr Claire Fuller, from NHS England, said: 'This is an important next step in the rollout of weight loss drugs, with community-based services now able to offer this treatment from today. 'We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health – and greater access to weight loss drugs will make a significant difference to the lives of those people. 'These drugs are an important tool alongside the range of wraparound NHS support and advice on good nutrition and increasing physical activity, which will be vital in helping some people lose weight and reduce their risk of serious long-term conditions. 'While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'While we recognise the potential benefits of weight loss drugs, we know many GPs are concerned about the implications of the rollout of weight loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments. 'The college shares these concerns, which is why we were pleased NHS England suggested a phased roll-out of Mounjaro as a treatment for weight loss. As and when this is escalated, appropriate resourcing for general practice – including access to 'wraparound' services – and training for GPs must follow. GLP-1s like #Ozempic, #Saxenda, #Wegovy, or #Mounjaro are not an easy #weightloss hack. Find out more about:🔵what they are ❓🔵how they're used 💊🔵who they help 💪 🔗Learn more: — EU Medicines Agency (@EMA_News) January 4, 2025 She added: 'GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely. 'More widely, whilst weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. 'We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later.' Dr Hawthorne said there is no 'one size fits all approach' and that the rollout of the jabs should not 'come at the expense of other weight loss service'. She continued: 'The roll-out of weight loss medications in the NHS will need to be consistently evaluated to ensure that there is evidence that these prescriptions are of long-term benefit to patients.' Olivier Picard, chairman of the National Pharmacy Association, said: 'The demand for weight loss jabs continues to rise sharply, and more GPs have been directing patients back to pharmacies after initial inquiries, to access these treatments privately. 'As the NHS is now moving to implement National Institute for Health and Care Excellence (Nice) guidance, and tirzepatide becomes prescribable to more patients, we expect to see prescription volumes increase rapidly. 'However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy. 'Pharmacists are experts in medication and many of us have lots of experience delivering weight loss injections as part of a package of care including lifestyle advice. 'We are well placed to help roll out weight loss treatment on the NHS, with the right funding to support it. 'The biggest concern we have is that prescribing these medications alone misses the point. 'They should be part of a comprehensive weight management strategy – combining lifestyle coaching, exercise, and nutritional guidance. In reality, many GPs lack the bandwidth to deliver the level of support needed to ensure proper understanding and follow-up. 'As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends – simply because the foundational lifestyle changes weren't addressed.' Around 29% of the adult population in the UK is obese. Health Secretary Wes Streeting said: 'Obesity is now one of the leading causes of ill health, costing the NHS billions. Yet we now have the science, technology, and knowledge to end the obesity epidemic, if we seize this opportunity. 'Obesity jabs are used by 1.5 million people in the UK, mainly through private prescriptions. The NHS was founded on a promise to 'universalise the best', and this Government is determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay. 'This rollout is an important step in making these medicines more widely available, and beginning to shift the focus of healthcare from sickness to prevention, which our forthcoming 10-year plan will deliver.'